Africa’s biotech sector is experiencing unprecedented momentum, yet many innovations struggle to reach the market. This high-level session, “From Lab to Market: Unlocking Biotech Innovations for Africa’s Public Health Future,” convened by Market Access Africa, explores how to bridge the “valley of death” between research and commercialization. Featuring leading innovators, investors, ecosystem enablers, and policy makers, the discussion will spotlight strategies for strengthening incubation, regulatory alignment, regional manufacturing, and financing ecosystems — turning biotech innovations into scalable, accessible, and sustainable solutions that advance health sovereignty under Africa CDC’s New Public Health Order.
